Nicolau–Balus syndrome

From WikiMD's WELLNESSPEDIA


Nicolau–Balus syndrome
Synonyms Nicolau–Balus syndrome
Pronounce N/A
Specialty N/A
Symptoms Palmoplantar keratoderma, lichen planus, dyschromatosis
Complications Skin cancer
Onset Childhood
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Clinical evaluation, genetic testing
Differential diagnosis Lichen planus, dyschromatosis universalis hereditaria
Prevention N/A
Treatment Topical corticosteroids, emollients, retinoids
Medication N/A
Prognosis Variable, risk of skin cancer
Frequency Rare
Deaths N/A


Nicolau–Balus syndrome is a rare genodermatosis characterized by the presence of multiple cutaneous and systemic abnormalities. It is also known as angiokeratoma corporis diffusum with neurodegenerative disorder. This syndrome is named after the Romanian dermatologists Aurelian Nicolau and Constantin Băluț, who first described the condition.

Clinical Features[edit]

The primary clinical features of Nicolau–Balus syndrome include:

Diagnosis[edit]

The diagnosis of Nicolau–Balus syndrome is primarily clinical, based on the characteristic skin lesions and associated systemic features. Histopathology of the skin lesions typically shows angiokeratoma with hyperkeratosis, acanthosis, and dilated blood vessels in the dermis. Genetic testing may also be performed to identify any underlying genetic mutations associated with the syndrome.

Management[edit]

There is no specific treatment for Nicolau–Balus syndrome. Management is primarily supportive and symptomatic, focusing on the individual patient's needs. This may include:

Prognosis[edit]

The prognosis for individuals with Nicolau–Balus syndrome varies depending on the severity of the systemic involvement. Early diagnosis and supportive care can improve the quality of life for affected individuals.

See Also[edit]

References[edit]

External Links[edit]

-

This article is a stub related to hospitals. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.